Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 02/24 04:15:31 pm
104.175 EUR   -0.88%
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
02/23DJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22DJBAYER : Details Financing Plan for Monsanto Deal
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Bayer Stops Sale of Glucose Meter Business

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2013 | 12:07pm CET

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at hendrik.varnholt@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
02/23DJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22DJBAYER : Details Financing Plan for Monsanto Deal
02/22 EU regulators set to clear Dow, DuPont deal - sources
02/22 Covestro parent Bayer non-committal on any sale to industry peer
02/22DJBAYER : CEO Confident Monsanto Purchase Will Be Approved by End of Year -- Updat..
02/22 BAYER : Financial News Conference -- Address by Johannes Dietsch -- Member of th..
02/22 BAYER : Financial News Conference -- Address by Werner Baumann -- Chairman of th..
02/22DJBAYER : Upbeat Bayer Posts Lower Profit With Monsanto in its Sights--Update
02/22 FISCAL 2016 : -- Another record year for Bayer - good progress with the acquisit..
More news
Sector news : Pharmaceuticals - NEC
04:12pDJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
02:02pDJASTRAZENECA : Gets Approval for Drug Treating Hyperkalaemia
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/23 BAYER'S Q4 : Mixed Signals For Investors
02/23 WALL STREET BREAKFAST : Earnings Season Winds Down
02/23 Bayer outlines Monsanto deal financing
02/23 M&A Repositioning Agriculture For Long-Term Growth
02/22 Bayer A.G.'s (BAYZF) CEO Werner Baumann on Q4 2016 Results - Earnings Call Tr..
Advertisement
Financials (€)
Sales 2017 49 078 M
EBIT 2017 9 510 M
Net income 2017 5 402 M
Debt 2017 11 230 M
Yield 2017 2,71%
P/E ratio 2017 16,48
P/E ratio 2018 14,85
EV / Sales 2017 2,00x
EV / Sales 2018 1,92x
Capitalization 86 912 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 111 €
Spread / Average Target 5,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG9.86%92 031
JOHNSON & JOHNSON3.74%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.3.42%206 688
NOVARTIS AG3.51%201 806
MERCK & CO., INC.10.91%181 558
More Results